CTRI Number |
CTRI/2024/04/065626 [Registered on: 12/04/2024] Trial Registered Prospectively |
Last Modified On: |
09/04/2024 |
Post Graduate Thesis |
Yes |
Type of Trial |
Interventional |
Type of Study
|
Drug Surgical/Anesthesia |
Study Design |
Randomized, Parallel Group, Active Controlled Trial |
Public Title of Study
|
Comparison of fentanyl and nalbuphine in attenuating blood pressure and heart rate during laryngoscopy in patients undergoing general anaesthesia. |
Scientific Title of Study
|
Comparative study of intravenous bolus doses of nalbuphine with fentanyl in attenuating hemodynamic response to laryngoscopy in patients undergoing nasal intubation for oral and maxillofacial surgery (OMFS) under general anesthesia |
Trial Acronym |
Nil |
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Shubhangi |
Designation |
Junior Resident |
Affiliation |
Institute of Medical Sciences, BHU |
Address |
Department of Anesthesiology
Institute of Medical Sciences
Banaras Hindu University
Varanasi UTTAR PRADESH 221005 India |
Phone |
7903701788 |
Fax |
|
Email |
sipushubhangi@gmail.com |
|
Details of Contact Person Scientific Query
|
Name |
Atul Kumar Singh |
Designation |
Associate Professor |
Affiliation |
Institute of Medical Sciences, BHU |
Address |
Department of Anesthesiology
Institute of Medical Sciences
Banaras Hindu University
Varanasi UTTAR PRADESH 221005 India |
Phone |
8317010317 |
Fax |
|
Email |
atulksingh84@gmail.com |
|
Details of Contact Person Public Query
|
Name |
Atul Kumar Singh |
Designation |
Associate Professor |
Affiliation |
Institute of Medical Sciences, BHU |
Address |
Department of Anesthesiology
Institute of Medical Sciences
Banaras Hindu University
Varanasi UTTAR PRADESH 221005 India |
Phone |
8317010317 |
Fax |
|
Email |
atulksingh84@gmail.com |
|
Source of Monetary or Material Support
|
|
Primary Sponsor
|
Name |
Nil |
Address |
Institute of Medical Sciences
Banaras Hindu University |
Type of Sponsor |
Government medical college |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Shubhangi |
Faculty of Dental Sciences,IMS, BHU |
Trauma Centre, Institute of Medical Sciences, BHU Varanasi UTTAR PRADESH |
7903701788
sipushubhangi@gmail.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
Institutional ethics committee |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
(1) ICD-10 Condition: O||Medical and Surgical, |
|
Intervention / Comparator Agent
|
Type |
Name |
Details |
Intervention |
Intravenous bolus premeditation dose of nalbuphine |
Administration of intravenous bolus dose of nalbuphine as premedication in patients undergoing maxillofacial surgeries to see their efficacy in attenuating hemodynamic response to laryngoscopy during nasal intubation |
Comparator Agent |
Intravenous premeditation bolus dose of fentanyl |
Effect of intravenous premedication bolus dose of nalbuphine will be compared with intravenous premedication bolus dose of fentanyl |
|
Inclusion Criteria
|
Age From |
18.00 Year(s) |
Age To |
60.00 Year(s) |
Gender |
Both |
Details |
Undergoing nasal intubation in oral and maxillofacial surgery.
Patient belonging to American society of Anaesthesiologist physical 1 and 2. |
|
ExclusionCriteria |
Details |
Age>60 or <18
Preoperative hypertension, coronary artery disease (CAD), cardiac conduction defects, congenial heart disease, hemodynamic instability and associated comorbidity.
Obesity ( body mass index >30 kg per square meter).
Mouth opening less than or equal to 2.5 fingers or inability to do laryngoscopy.
MPG grade 4.
Patients with nasal fracture.
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
Method of Concealment
|
Not Applicable |
Blinding/Masking
|
Double Blind Double Dummy |
Primary Outcome
|
Outcome |
TimePoints |
Compare the efficacy between nalbuphine and fentanyl in attenuating hemodynamic response to laryngoscopy and nasal intubation. |
Intraoperatively |
|
Secondary Outcome
|
Outcome |
TimePoints |
Compare Post operative sedation
Compare post operative pain. |
Post operatively |
|
Target Sample Size
|
Total Sample Size="200" Sample Size from India="200"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
Phase of Trial
|
Phase 3/ Phase 4 |
Date of First Enrollment (India)
|
19/05/2024 |
Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
Estimated Duration of Trial
|
Years="0" Months="6" Days="0" |
Recruitment Status of Trial (Global)
|
Open to Recruitment |
Recruitment Status of Trial (India) |
Not Yet Recruiting |
Publication Details
|
N/A |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
Brief Summary
|
General Anesthesia administration involves laryngoscopy and endotrachial intubation which are associated with the pressor response and can lead to tachycardia, hypertension and arrhythmias, which can be deleterious in both healthy and compromised patients and hence response needs to be suppressed.Nasal intubation is the commonest endotracheal intubation method practiced during general anaesthesia in oral and maxillofacial surgeries. This study is designed to compare the efficacy of nalbuphine and fentanyl in attenuation of haemodynamic response in patients undergoing nasal intubation under general anaesthesia. |